# \SINGLE ASCENDING DOSE (SAD) PHASE I STUDY

> **NIH NIH N01** · PPD DEVELOPMENT LP · 2024 · $2,773,098

## Abstract

This study is part of the NIH’s Helping to End Addiction Long-term (HEAL) initiative to speed scientific solutions to understand the basis of pain and enhance clinical pain management.

## Key facts

- **NIH application ID:** 11211253
- **Project number:** 271201600005I-0-759502400001-1
- **Recipient organization:** PPD DEVELOPMENT LP
- **Principal Investigator:** CRAIG BOYLE
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $2,773,098
- **Award type:** —
- **Project period:** 2016-07-08 → 2026-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11211253

## Citation

> US National Institutes of Health, RePORTER application 11211253, \SINGLE ASCENDING DOSE (SAD) PHASE I STUDY (271201600005I-0-759502400001-1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/11211253. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*